Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Orthopedics ; 44(3): e373-e377, 2021.
Article in English | MEDLINE | ID: mdl-33238011

ABSTRACT

Upper extremity surgeons perform diverse operations, including hand surgery, microsurgery, and shoulder/elbow arthroscopy and arthroplasty. Declining orthopedic reimbursement rates may encourage surgeons to adjust their case mix, favoring a shift toward procedures with higher compensation. To determine whether upper extremity surgeons and hand-fellowship trainees may be financially incentivized to perform more shoulder/elbow procedures than hand procedures in a hospital-based setting, relative value unit (RVU) compensation rates were compared for these 2 fields. Using Centers for Medicare & Medicaid Services-assigned work RVUs (wRVU) and National Surgical Quality Improvement Program operative time data, wRVU compensation rates per minute of operative time were determined for common shoulder/elbow surgeries. Overall nonweighted and weighted wRVU/min averages were calculated for hospital-based shoulder/elbow and hand surgery. A total of 27 shoulder/elbow procedures and 53 hand surgery procedures were analyzed. Nonweighted comparison showed shoulder/elbow surgery had a higher wRVU/min (0.19±0.03 vs 0.14±0.05, P<.0001) vs hand surgery. When weighted by procedure frequency, shoulder/elbow surgery also had higher wRVU/min (0.19±0.02 vs 0.15±0.05, P<.0001). Fourteen of the 27 shoulder/elbow procedures were compensated either the same wRVU/min or more than all hand procedures except for epicondyle debridement and flexor tendon bursectomy. Almost half of commonly performed shoulder/elbow procedures were compensated at greater rates than most hand procedures in a hospital-based setting. This disproportionate compensation may affect upper extremity surgeons' case mix and motivate providers and hand-fellowship trainees to seek additional training in shoulder arthroplasty and arthroscopy to supplement their practice. [Orthopedics. 2021;44(3):e373-e377.].


Subject(s)
Insurance, Health, Reimbursement/economics , Operative Time , Orthopedic Procedures/economics , Orthopedics/economics , Centers for Medicare and Medicaid Services, U.S. , Elbow/surgery , Hand/surgery , Hospitals , Humans , Insurance, Health, Reimbursement/statistics & numerical data , Orthopedic Procedures/statistics & numerical data , Orthopedics/education , Relative Value Scales , Shoulder/surgery , United States
2.
J Trauma Acute Care Surg ; 79(5): 870-6, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26496115

ABSTRACT

BACKGROUND: Heterotopic ossification (HO) is a debilitating complication of burn injury; however, incidence and risk factors are poorly understood. In this study, we use a multicenter database of adults with burn injuries to identify and analyze clinical factors that predict HO formation. METHODS: Data from six high-volume burn centers, in the Burn Injury Model System Database, were analyzed. Univariate logistic regression models were used for model selection. Cluster-adjusted multivariate logistic regression was then used to evaluate the relationship between clinical and demographic data and the development of HO. RESULTS: Of 2,979 patients in the database with information on HO that addressed risk factors for development of HO, 98 (3.5%) developed HO. Of these 98 patients, 97 had arm burns, and 96 had arm grafts. When controlling for age and sex in a multivariate model, patients with greater than 30% total body surface area burn had 11.5 times higher odds of developing HO (p < 0.001), and those with arm burns that required skin grafting had 96.4 times higher odds of developing HO (p = 0.04). For each additional time a patient went to the operating room, odds of HO increased by 30% (odds ratio, 1.32; p < 0.001), and each additional ventilator day increased odds by 3.5% (odds ratio, 1.035; p < 0.001). Joint contracture, inhalation injury, and bone exposure did not significantly increase odds of HO. CONCLUSION: Risk factors for HO development include greater than 30% total body surface area burn, arm burns, arm grafts, ventilator days, and number of trips to the operating room. Future studies can use these results to identify highest-risk patients to guide deployment of prophylactic and experimental treatments. LEVEL OF EVIDENCE: Prognostic study, level III.


Subject(s)
Burns/complications , Disability Evaluation , Ossification, Heterotopic/epidemiology , Rehabilitation Research , Adolescent , Adult , Age Distribution , Aged , Burn Units , Burns/diagnosis , Burns/therapy , Cluster Analysis , Combined Modality Therapy , Databases, Factual , Female , Follow-Up Studies , Humans , Independent Living , Injury Severity Score , Logistic Models , Male , Middle Aged , Multivariate Analysis , Ossification, Heterotopic/etiology , Ossification, Heterotopic/therapy , Prevalence , Prognosis , Risk Factors , Severity of Illness Index , Sex Distribution , Statistics as Topic , United States , Wound Healing/physiology , Young Adult
3.
Exp Biol Med (Maywood) ; 228(6): 697-705, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12773701

ABSTRACT

Vascular endothelial growth factor (VEGF) expression in murine peritoneal macrophages is strongly upregulated by hypoxia via transcriptional and posttranscriptional mechanisms. Interferon-gamma (IFN-gamma) with Escherichia coli lipopolysaccharide (LPS) also upregulates expression of VEGF, as well as of the inducible nitric oxide synthase (iNOS). Hypoxia (1% O(2)) upregulates VEGF expression in macrophages from both wild-type and iNOS knockout mice, indicating that hypoxic upregulation of VEGF is independent of iNOS. However, the iNOS inhibitor aminoguanidine (AG) decreases the VEGF expression induced by LPS/IFN-gamma, indicating an important role for NO. NO-dependent induction of VEGF is strongly dependent on cell density. LPS/IFN-gamma treatment induces minimal VEGF protein expression in macrophages cultured at low cell densities (<0.25 x 10(6) cells/cm(2)); at higher cell densities (>0.25 x 10(6) cells/cm(2)) that lead to conditions of pericellular hypoxia, however, induction of VEGF expression was strong. Transient transfection of RAW 264.7 cells with luciferase reporter constructs of the murine VEGF promoter indicates that both hypoxia and LPS/IFN-gamma independently induce VEGF promoter activity, irrespective of cell density. Although LPS/IFN-gamma treatment induces transcriptional activation of the VEGF promoter, significant levels of VEGF protein are only expressed by cells at high density under conditions of pericellular hypoxia. This suggests an important regulatory role for hypoxia at the posttranscriptional level. Deletion analysis of the VEGF promoter shows that the hypoxia response element region and its immediate flanking sequences are essential for both hypoxia and LPS/IFN-gamma-induced VEGF promoter activation.


Subject(s)
Endothelial Growth Factors/biosynthesis , Gene Expression Regulation/drug effects , Hypoxia/metabolism , Intercellular Signaling Peptides and Proteins/biosynthesis , Lymphokines/biosynthesis , Macrophages/drug effects , Macrophages/metabolism , Nitric Oxide/pharmacology , Animals , Cell Count , Endothelial Growth Factors/genetics , Female , Gene Expression Regulation/physiology , Genes, Reporter , Intercellular Signaling Peptides and Proteins/genetics , Interferon-gamma/pharmacology , Lipopolysaccharides/pharmacology , Luciferases/genetics , Lymphokines/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Peritoneum/cytology , Promoter Regions, Genetic/genetics , Transfection , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...